Company / Current Assets
Biohaven Ltd. Current Assets History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$538.5M
FY2024
5-year range
$94.8M / $587.0M
FY2021-FY2024
Trend
+21.7%
vs FY2023
Sector context
#109 of 213
Health Care
What the data says
At $538M, Biohaven Ltd.'s current assets ranks #109 of 213 in the Health Care sector. Declined from $587M to $538M over the past 2 years.
Based on SEC 10-K filings.
$538M in FY2024 with a 3-year CAGR of +78.4%.
Declined from $587M to $538M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +78.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 213 in Health CareTop 51% of 213This company $538.5M Sector average $2.5B
▼
-78.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +78.4%, indicating consistent growth.
- In FY2024, current assets increased 21.7% year-over-year.
- Ranks #109 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $538.5M | +21.7% |
| FY2023 | $442.4M | -24.6% |
| FY2022 | $587.0M | +519.0% |
| FY2021 | $94.8M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026